Close Close Close Close 
Aquis Corporate Finance
M&A Advisory FirmsAbout Aquis Corporate Finance
AQUIS is an independent corporate finance firm specialising in corporate acquisitions, acquisition guidance and acquisition mediation. Its main focus is on guidance and advice on acquisitions of SMEs and their underlying business real estate. We rely on years of experience and a team of passionate advisers.
AQUIS carries out these advisory assignments for both prospective buyers and prospective sellers and can rely on an extensive network of business contacts. When carrying out its assignments, AQUIS can also rely on its privileged relationship with a large number of active candidate buyers, whether private, industrial or financial.
AQUIS is Belgian M&A boutique with offices in Ghent and Bruges.
M&A expertise
- M&A Advisory
- Financing
- Valuation
- Strategy Advisory
Industry Expertise
Organisation Information
Join Dealsuite
Europe's Largest Market Network for M&A
Meet Qualified Buyers- Expand Your Network
- Receive Daily Dealflow
Contacts
Contacts
Active projects
- Sell-side
- Buy-side
Track record
12 completed deals-
Most active in
Transport & Logistics
-
Made most deals in
Belgium
-
Median deal size
€ 5 - 25 million
-
Sell side deals
50.0 %
-
4 June 2026
Gilbert De Clercq has acquired Transport Dirk Verdoodt
Gilbert De Clercq has acquired the operations of Transport Dirk Verdoodt. With this transaction, Gilbert De Clercq strengthens its local presence while further expanding its European logistics capabilities, which aligns perfectly with its strategic ambition. The merger with Gilbert De Clercq provides a solid foundation for further growth and continuity for customers, employees, and other stakeholders. Aquis Corporate Finance advised the Verdoodt family throughout the entire process of selling the business to Gilbert De Clercq.
Transaction value: UndisclosedBelgium- Transport & Logistics
-
-
18 May 2026
Studibo completed acquisition of Stabex
Stabex, specialized in stability studies and structural engineering, joins Studibo. With this move, Studibo strengthens its position as a leading multidisciplinary group of study and consulting firms in the construction and infrastructure sector, active in the Benelux, France, Germany and Scandinavia, and supported by IceLake Capital. The addition of Stabex further expands Studibo's expertise within stability and structural engineering, strengthening the complementary range of structural engineering and engineering services within the group.
Transaction value: UndisclosedBelgium- Real Estate Services
- Architect/engineering firm Architect/engineering firm
-
-
1 April 2026
two MBI Candidates completed the acquisition of Raverco
Raverco NV, an established player and specialist in the import, storage and distribution of (non-)European game and meat products for customers in retail, catering and food service among others, has been acquired by two MBI candidates. The buyers, Mr. Jan Lombaerts and Mr. Christophe Soenen, are taking over the company with the ambition to further build on Raverco's strong reputation and market position as a specialized partner within its niche.
Transaction value: UndisclosedBelgium- Specialty Retailers
-
-
3 March 2026
Pharma Chemicals Acquired by Companions
Proud to share a new Aquis Corporate Finance transaction: Companions acquires Pharma Chemicals through new vertical Substera group. Aquis acted as the financial advisor for Pharma Chemicals. Ever needed tailored medicine from your local pharmacy? A specific dosage of active substance or one free of an allergen? That’s where Pharma Chemicals plays a vital role: sourcing, analyzing, repackaging, and distributing high-quality pharmaceutical Active Pharmaceutical Ingredients (APIs) and excipients. Founded in 2017 and operational in Belgium and France, they have built a trusted position serving most Belgian pharmacies, hospitals and wholesalers, while holding over 90% market penetration among France's large-scale compounders. Michael Hillaert will lead Pharma Chemicals and Substera Group. A word of gratitude to Michael Hillaert; Tieme Leyseele; Ger van Jeveren and Joeri Van den Acker thanks for your trust in our guidance. The dedicated and highly professional team of Companions: Jeremy Schuermans, Fabian Van Kerckhove, Cedric Suykens and Bob Roels Felix Dobbelaere from Eubelius for the great teamwork
Transaction value: € 5 - 25 millionBelgium- Specialty Chemicals
-
-
3 March 2026
Companions acquires Pharma Chemicals
Companions acquires Pharma Chemicals through new vertical Substera group. Aquis acted as the financial advisor for Pharma Chemicals. Ever needed tailored medicine from your local pharmacy? A specific dosage of active substance or one free of an allergen? That’s where Pharma Chemicals plays a vital role: sourcing, analyzing, repackaging, and distributing high-quality pharmaceutical Active Pharmaceutical Ingredients (APIs) and excipients.
Transaction value: UndisclosedBelgium- Pharmaceuticals
-
